YA II PN, Ltd. 13D and 13G filings for Nascent Biotech, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 5:10 pm Sale |
2023-12-31 | 13G | Nascent Biotech, Inc. NBIO |
YA II PN, Ltd. | 0 0.000% |
-13,358,683 (Position Closed) |
Filing |
| 2023-01-03 4:09 pm Purchase |
2022-12-31 | 13G | Nascent Biotech, Inc. NBIO |
YA II PN, Ltd. | 13,358,683 9.990% |
365,837 (+2.82%) |
Filing |
| 2022-08-31 6:45 pm Purchase |
2022-08-30 | 13G | Nascent Biotech, Inc. NBIO |
YA II PN, Ltd. | 12,992,846 9.990% |
12,992,846 (New Position) |
Filing |